Itolizumab for COVID

Itolizumab is a humanised anti-CD6 monoclonal antibody, It is a molecule made in a lab using living organisms. When administered , it acts as an antibody which can restore the immune system’s attack on foreign bodies. Itolizumab is used to treat a skin condition called psoriasis and is now being tried on COVID -19 patients through clinical trials .